Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
B12 Max Metylo is a dietary supplement or food for special medical purposes (FSMP) containing a high dose of methylcobalamin, the biologically active coenzyme form of vitamin B12. Developed and marketed by IBSS Biomed, it is used to manage vitamin B12 deficiency and support the proper functioning of the nervous and immune systems, as well as to maintain normal homocysteine metabolism and red blood cell production. Methylcobalamin serves as a critical cofactor for the enzyme methionine synthase, which facilitates the remethylation of homocysteine to the essential amino acid methionine. This biochemical pathway is vital for DNA synthesis, methylation processes, and the maintenance of the myelin sheath surrounding nerve fibers. Unlike cyanocobalamin, methylcobalamin does not require metabolic conversion to be utilized by the body.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylcobalamin.